| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.005 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.009 |